NEW YORK (GenomeWeb) – Link Technologies today announced it has signed two new Japanese distributors, Tokyo-based Cosmo Bio and Osaka-based Shigematsu.
The firms will work alongside Gene Design to provide Bellshill, Scotland-based Link's reagents for oligonucleotide synthesis and modification.
"Japan is an important market for us, but also a complex one," Link CEO David Ricketts said in a statement. "It is essential therefore that we reach customers by more than one channel, to increase choice and value for customers seeking to source and use our products."
Financial and other terms of the deals were not disclosed.